Remove 2010 Remove Competition Remove Leads
article thumbnail

Highly Cited Researchers 2021: How nations and institutions foster exceptional performance

Clarivate

These highly cited papers rank in the top 1% by citations for field and year from 2010 – 2020. We’re pleased to showcase some institutions that excel in a competitive global environment, supporting their Highly Cited Researchers in a way that encourages collaboration, facilitates career growth and accelerates highly innovative research.

article thumbnail

Call to arms as UK falls back in medicines manufacturing

pharmaphorum

Since 2010, the UK has fallen from 4th to 98th place in overall trade balance in pharmaceuticals, due to fierce global competition, according to the MMIP. Over the same period, similar countries – including Ireland, France, and Germany – have been moving to boosting manufacturing productivity, output, and exports. .”

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Global comparator data signal “alarm bells” for UK Government, says APBI

pharmaphorum

Latest UK Life Sciences Competitive Indicators “ought to ring alarm bells across Government,” says ABPI. Richard Torbett, chief executive at the Association of the British Pharmaceutical Industry (ABPI) said Life Sciences Competitive Indicators (LSCI) data published last week “ought to ring alarm bells across Government”.

article thumbnail

Achieving scale up success under economic uncertainty

European Pharmaceutical Review

Market uncertainty Rising operational costs, stiffening competition, ongoing patent expirations, evolving environmental and social governance requirements and increasing pressure on drug prices mean the industry will have to navigate thoughtfully to be successful amid this complicated mix of financial and strategic risks.

article thumbnail

Comparison of Humira biosimilars in the US and Europe

Pharmaceutical Technology

Biosimilars are an important tool to facilitate competition, lower the price of drugs, and create savings across the board. Until 2010, no regulatory approval pathway for biosimilars existed in the US and the first biosimilar was only approved in the US in 2015. The biosimilar market in the US may progress differently this time.

article thumbnail

The Fastest Growing Companies in Boston Hiring For Sales

CloserIQ

They’ve worked with leading clients such as Twitter and Mercedes Benz. Founded 2010. Founded 2010. Founded 2010. Cybereason’s workplace culture is known to be fast-paced and competitive, with plenty of opportunities for learning. Founded 2007. 501-1000 employees. million in funding. See open roles. See open roles.

Sales 76
article thumbnail

Virtual Reality Training For Medical Device Sales Reps With David Howe

Evolve Your Success

With VR simulations, sales reps can now hone their skills in lifelike scenarios, giving them a competitive edge in the field. I left in 2010 and I went into software and technology. I landed this competitive scholarship at the National Cancer Institute at school. I came back eight years later to Osso. I was a pre-med undergrad.

Training 130